Recent studies of 27 instances of endometrial adenocarcinoma samples found that positive PD-L1 expression was observed in tumor cells in 3.7% of cases, while immune cells showed positive PD-L1 expression in 7.4% of cases (78). This evidence concerns the gene CD274 and endometrium adenocarcinoma.